Goldman Sachs Group »

Acelrx Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $29k 28k 1.03

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Micron Technology CMN (MU)
Microsoft Corp CMN (MSFT)
Taiwan Semiconductor Manufac CMN (TSM)
Alphabet CMN (GOOGL)
Sandisk Corp CMN (SNDK)
Amazon CMN (AMZN)
Invesco Qqq Tr CMN (QQQ)
Broadcom CMN (AVGO)
Vaneck Etf Trust CMN (SMH)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Alphabet CMN (GOOG)

View all positions for Goldman Sachs Group

Top funds holding Acelrx Pharmaceuticals

Rosalind Advisors
AIGH Capital Management
Rock Springs Capital Management
Nantahala Capital Management
Bleichroeder
Cantor Fitzgerald, L. P.
Dauntless Investment Group
Vanguard Capital Management
Caption Management
Almitas Capital
Geode Capital Management
Shay Capital
Vanguard Fiduciary Trust
GSA Capital Partners
Diadema Partners

View all funds holding Acelrx Pharmaceuticals